Home›Stock Screener›Global Health›Quarterly Results

Global Health Quarterly Results

Latest Quarter Net Profit
₹219 Cr
QSept 2026
Quarterly Results

Global Health quarterly results. In Sept 2026, Global Health (MEDANTA) reported revenue ₹1,493 Cr and net profit ₹219 Cr — revenue +31.5% YoY. Also explore MEDANTA price trends to track price trends across different timeframes.

MEDANTA Quarterly Results — Revenue, Profit & EPS Highlights

Global Health latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit MEDANTA share price.

  • Revenue of ₹1,493 Cr in Sept 2026 (+24.8% vs Mar 2026, +31.5% vs Sept 2025)
  • Net Profit of ₹219 Cr in Sept 2026 (+54.2% vs Mar 2026, +38.6% vs Sept 2025)
  • EBITDA of ₹394 Cr in Sept 2026 (+40.2% vs Mar 2026)
  • Operating Margin of 25.0% in Sept 2026 (+4.0pp vs Mar 2026)
  • Earnings Per Share of ₹8.21 in Sept 2026 (+53.2% vs Mar 2026)

Global Health Quarterly Results — Revenue, EBITDA, Net Profit & EPS

MEDANTA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 1,493 1,196 1,326 1,135 954 24.8% 31.5%
Net Profit (₹ Cr) 219 142 157 158 101 - -
EBITDA (₹ Cr) 394 281 309 267 198 - -
EPS (₹) 8.21 5.36 5.91 5.89 3.77 - -
Operating Margin (%) 25.0% 21.0% 22.0% 21.0% 19.0% - -

MEDANTA Share Price Trend — 1-Year Movement Across Quarterly Results

Global Health 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View Global Health yearly highs lows for the annual high/low range and current price position.

Profitability Ratios

Profit Margin 14.7%
EBITDA Margin 26.4%
Operating Margin 25.0%
ROE (Annual) 22.0%

Balance Sheet Highlights

Total Assets ₹5,905 Cr
Total Equity ₹3,984 Cr
Current Assets ₹ Cr
Current Liabilities ₹1,294 Cr

Cash Flow Analysis

Operating Cash Flow ₹714 Cr
Investing Cash Flow ₹-1,089 Cr
Financing Cash Flow ₹272 Cr
Net Cash Flow ₹-103 Cr

Current Market Data

Current Price ₹1478.30
Exchange NSE
Last Updated Nov 19, 2026

MEDANTA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Global Health latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores